Who owns CONTINEUM THERAPEUTICS INC?
- Ticker: CTNM
- CUSIP Number: 21217b100
Tip: Access positions for across all investors
Analyze quarterly positions in Contineum Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Contineum Therapeutics stock
Who bought or sold CONTINEUM THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Suvretta Capital Management | 2.1M | $36M | 100% | Jun 2024 |
|
Johnson & Johnson | 2.0M | $38M | 0% | Sep 2024 |
|
Perceptive Advisors | 1.5M | $29M | -3% | Sep 2024 |
|
Franklin Resources | 1.4M | $24M | 131% | Sep 2024 |
|
Versant Venture Management | 918k | $18M | 0% | Sep 2024 |
|
Hillhouse Capital Advisors | 669k | $13M | 0% | Sep 2024 |
|
Samsara BioCapital | 589k | $11M | 0% | Sep 2024 |
|
Vanguard Group | 472k | $8.3M | 100% | Jun 2024 |
|
Altium Capital Management | 429k | $7.6M | 100% | Jun 2024 |
|
BlackRock | 405k | $7.7M | 100% | Sep 2024 |
|
BlackRock | 396k | $7.0M | 100% | Jun 2024 |
|
Baker Bros. Advisors | 313k | $6.0M | 0% | Sep 2024 |
|
Casdin Capital | 297k | $5.7M | 0% | Sep 2024 |
|
Squarepoint Ops | 150k | $2.6M | 100% | Jun 2024 |
|
Geode Capital Management | 129k | $2.5M | -18% | Sep 2024 |
|
State Street Corporation | 92k | $1.6M | 100% | Jun 2024 |
|
Saturn V Capital Management | 73k | $1.3M | 100% | Jun 2024 |
|
Driehaus Capital Management | 67k | $1.3M | 0% | Sep 2024 |
|
Northern Trust | 63k | $1.2M | 100% | Sep 2024 |
|
Charles Schwab Investment Management | 43k | $829k | -16% | Sep 2024 |
|
Board of Trustees of The Leland Stanford Junior University | 39k | $744k | 0% | Sep 2024 |
|
Bank of New York Mellon | 14k | $271k | -30% | Sep 2024 |
|
Morgan Stanley | 12k | $209k | 100% | Jun 2024 |
|
Hrt Financial | 11k | $213k | 100% | Sep 2024 |
|
Winton Capital | 11k | $213k | 100% | Sep 2024 |
|
Barclays | 8.3k | $158k | 249% | Sep 2024 |
|
Bnp Paribas Arbitrage, Snc | 6.7k | $129k | 1249% | Sep 2024 |
|
Rhumbline Advisers | 6.0k | $116k | -10% | Sep 2024 |
|
Bank of America Corporation | 5.6k | $107k | 25% | Sep 2024 |
|
Citigroup | 4.9k | $93k | 219% | Sep 2024 |
|
Mirae Asset Global Etfs Holdings | 3.1k | $59k | 100% | Sep 2024 |
|
Jpmorgan Chase & Co | 2.5k | $48k | -16% | Sep 2024 |
|
Wells Fargo & Company | 2.1k | $40k | -19% | Sep 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 1.3k | $25k | 0% | Sep 2024 |
|
Royal Bank of Canada | 1.2k | $19k | 63% | Sep 2024 |
|
Summit Investment Advisors | 680.00 | $13k | 0% | Sep 2024 |
|
New York State Common Retirement Fund | 600.00 | $11k | -89% | Sep 2024 |
|
California State Teachers Retirement System | 420.00 | $8.0k | -17% | Sep 2024 |
|
Amalgamated Bank | 240.00 | $5.0k | 0% | Sep 2024 |
|
Harbor Capital Advisors | 168.00 | $3.0k | 100% | Sep 2024 |
|
Tower Research Capital | 94.00 | $1.7k | 100% | Jun 2024 |
|
NISA Investment Advisors | 29.00 | $554.999100 | 100% | Sep 2024 |
|
CWM | 28.00 | $1.0k | 100% | Sep 2024 |
|
Sterling Capital Management | 13.00 | $248.999400 | 100% | Sep 2024 |
|
Who sold out of Contineum Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Citadel Advisors | Jun 2024 | 128k | $2.3M |
Invesco | Jun 2024 | 11k | $190k |
Sandia Investment Management | Jun 2024 | 5.0k | $88k |
MetLife Investment Advisors | Jun 2024 | 1.9k | $34k |